European Archives - Page 519 of 1009 - European Medical Journal

Multiple Sclerosis Medication Effectively Inhibits SARS-CoV-2 Replication In Vitro

REPLICATION of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been shown to be inhibited by an antiviral medication approved in the treatment against multiple sclerosis in vitro.

EMJ Podcast: The Learning Never Stops

This week, Jonathan reflects on the importance of Continuous Medical Education for healthcare professionals.

Continuing Challenges in the Medical Management of Gestational Diabetes Mellitus

Gestational diabetes mellitus (GDM) is hyperglycaemia first detected in pregnancy, short of overt diabetes in pregnancy (DIP)…

EMJ Podcast: Affairs of the Heart

Jonathan sits down with Steve Westaby, Cardiac Surgeon, Author, and Pioneer of Circulatory Support Technology, to discuss innovation.

Peptides on Melanoma Surface Could Result in Immunogenic Vaccines

VACCINES against melanoma could be developed after new research has identified human leukocyte antigen (HLA)-peptides as unique markers for melanoma.

Can Human Skin Regenerate Scar Free?

WOUND treatment and prevention of the skin ageing process could be aided by a newly discovered genetic factor.

COVID-19 and The Cardiovascular System

Despite the respiratory tract being the most affected system, many other organs may be involved in Covid-19, including the cardiovascular system

A decade of innovation

In this infographic, we highlight some of the biggest shifts of the pharmaceutical industry over the past decade, with increased investment and development of biologics, recombinant DNA, and gene research.

Genomic Profiling and the Future of Early Breast Cancer Care

Hear from the experts in the field of early-stage breast cancer on the performance and utility of the Prosigna® breast cancer prognostic gene signature in this webinar.

Talking to Fran Ayalasomayajula

Fran Ayalasomayajula, Head of Population Health Portfolio, Worldwide Healthcare, HP, discusses scaling technological adoption, thought leadership, and the positive impact technology will have on future population health.